159 related articles for article (PubMed ID: 18277052)
21. Anticancer activities of parthenolide in primary effusion lymphoma preclinical models.
Karam L; Abou Staiteieh S; Chaaban R; Hayar B; Ismail B; Neipel F; Darwiche N; Abou Merhi R
Mol Carcinog; 2021 Aug; 60(8):567-581. PubMed ID: 34101920
[TBL] [Abstract][Full Text] [Related]
22. Nuclear factor-kappaB inhibition by parthenolide potentiates the efficacy of Taxol in non-small cell lung cancer in vitro and in vivo.
Zhang D; Qiu L; Jin X; Guo Z; Guo C
Mol Cancer Res; 2009 Jul; 7(7):1139-49. PubMed ID: 19584264
[TBL] [Abstract][Full Text] [Related]
23. Suppressed NF-kappaB and sustained JNK activation contribute to the sensitization effect of parthenolide to TNF-alpha-induced apoptosis in human cancer cells.
Zhang S; Lin ZN; Yang CF; Shi X; Ong CN; Shen HM
Carcinogenesis; 2004 Nov; 25(11):2191-9. PubMed ID: 15256485
[TBL] [Abstract][Full Text] [Related]
24. [Molecular mechanisms of parthenolide's action: Old drug with a new face].
Koprowska K; Czyz M
Postepy Hig Med Dosw (Online); 2010 Mar; 64():100-14. PubMed ID: 20354259
[TBL] [Abstract][Full Text] [Related]
25. Effect of parthenolide on growth and apoptosis regulatory genes of human cancer cell lines.
Al-Fatlawi AA; Al-Fatlawi AA; Irshad M; Rahisuddin ; Ahmad A
Pharm Biol; 2015 Jan; 53(1):104-9. PubMed ID: 25289524
[TBL] [Abstract][Full Text] [Related]
26. Combined Parthenolide and Balsalazide Have Enhanced Antitumor Efficacy Through Blockade of NF-κB Activation.
Kim SL; Kim SH; Park YR; Liu YC; Kim EM; Jeong HJ; Kim YN; Seo SY; Kim IH; Lee SO; Lee ST; Kim SW
Mol Cancer Res; 2017 Feb; 15(2):141-151. PubMed ID: 28108625
[TBL] [Abstract][Full Text] [Related]
27. Antiproliferative activity of parthenolide against three human cancer cell lines and human umbilical vein endothelial cells.
Parada-Turska J; Paduch R; Majdan M; Kandefer-Szerszeń M; Rzeski W
Pharmacol Rep; 2007; 59(2):233-7. PubMed ID: 17556802
[TBL] [Abstract][Full Text] [Related]
28. Identification of the genes involved in enhanced fenretinide-induced apoptosis by parthenolide in human hepatoma cells.
Park JH; Liu L; Kim IH; Kim JH; You KR; Kim DG
Cancer Res; 2005 Apr; 65(7):2804-14. PubMed ID: 15805281
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of NF-κB results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression.
Yu Z; Chen Y; Wang S; Li P; Zhou G; Yuan Y
Cancer Lett; 2018 Aug; 428():77-89. PubMed ID: 29705182
[TBL] [Abstract][Full Text] [Related]
30. Parthenolide sensitizes cells to X-ray-induced cell killing through inhibition of NF-kappaB and split-dose repair.
Mendonca MS; Chin-Sinex H; Gomez-Millan J; Datzman N; Hardacre M; Comerford K; Nakshatri H; Nye M; Benjamin L; Mehta S; Patino F; Sweeney C
Radiat Res; 2007 Dec; 168(6):689-97. PubMed ID: 18088190
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of NF-kappaB by combination therapy with parthenolide and hyperthermia and kinetics of apoptosis induction and cell cycle arrest in human lung adenocarcinoma cells.
Hayashi S; Sakurai H; Hayashi A; Tanaka Y; Hatashita M; Shioura H
Int J Mol Med; 2010 Jan; 25(1):81-7. PubMed ID: 19956905
[TBL] [Abstract][Full Text] [Related]
32. Parthenolide inhibits IkappaB kinase, NF-kappaB activation, and inflammatory response in cystic fibrosis cells and mice.
Saadane A; Masters S; DiDonato J; Li J; Berger M
Am J Respir Cell Mol Biol; 2007 Jun; 36(6):728-36. PubMed ID: 17272824
[TBL] [Abstract][Full Text] [Related]
33. Involvement of proapoptotic Bcl-2 family members in parthenolide-induced mitochondrial dysfunction and apoptosis.
Zhang S; Ong CN; Shen HM
Cancer Lett; 2004 Aug; 211(2):175-88. PubMed ID: 15219941
[TBL] [Abstract][Full Text] [Related]
34. Antiproliferative activities of parthenolide and golden feverfew extract against three human cancer cell lines.
Wu C; Chen F; Rushing JW; Wang X; Kim HJ; Huang G; Haley-Zitlin V; He G
J Med Food; 2006; 9(1):55-61. PubMed ID: 16579729
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of interleukin-12 production in lipopolysaccharide-activated mouse macrophages by parthenolide, a predominant sesquiterpene lactone in Tanacetum parthenium: involvement of nuclear factor-kappaB.
Kang BY; Chung SW; Kim TS
Immunol Lett; 2001 Jul; 77(3):159-63. PubMed ID: 11410248
[TBL] [Abstract][Full Text] [Related]
36. Natural products as promising targets in glioblastoma multiforme: a focus on NF-κB signaling pathway.
Soukhtanloo M; Mohtashami E; Maghrouni A; Mollazadeh H; Mousavi SH; Roshan MK; Tabatabaeizadeh SA; Hosseini A; Vahedi MM; Jalili-Nik M; Afshari AR
Pharmacol Rep; 2020 Apr; 72(2):285-295. PubMed ID: 32152926
[TBL] [Abstract][Full Text] [Related]
37. Thermosensitization by parthenolide in human lung adenocarcinoma A549 cells and p53- and hsp72-independent apoptosis induction via the nuclear factor-kappaB signal pathway.
Hayashi S; Hatashita M; Hayashi A; Matsumoto H; Shioura H; Kitai R
Int J Mol Med; 2008 May; 21(5):585-92. PubMed ID: 18425350
[TBL] [Abstract][Full Text] [Related]
38. Activation of nuclear factor-kappaB contributes to induction of death receptors and apoptosis by the synthetic retinoid CD437 in DU145 human prostate cancer cells.
Jin F; Liu X; Zhou Z; Yue P; Lotan R; Khuri FR; Chung LW; Sun SY
Cancer Res; 2005 Jul; 65(14):6354-63. PubMed ID: 16024638
[TBL] [Abstract][Full Text] [Related]
39. Repressed Ca(2+) clearance in parthenolide-treated murine brain bEND.3 endothelial cells.
Tsai TY; Lou SL; Cheng KS; Wong KL; Wang ML; Su TH; Chan P; Leung YM
Eur J Pharmacol; 2015 Dec; 769():280-6. PubMed ID: 26607466
[TBL] [Abstract][Full Text] [Related]
40. Parthenolide and costunolide reduce microtentacles and tumor cell attachment by selectively targeting detyrosinated tubulin independent from NF-κB inhibition.
Whipple RA; Vitolo MI; Boggs AE; Charpentier MS; Thompson K; Martin SS
Breast Cancer Res; 2013; 15(5):R83. PubMed ID: 24028602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
